{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:31:11Z","timestamp":1789594271307,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["5P42ES010337"],"award-info":[{"award-number":["5P42ES010337"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR001442"],"award-info":[{"award-number":["5UL1TR001442"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK106419"],"award-info":[{"award-number":["R01DK106419"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK120515"],"award-info":[{"award-number":["P30DK120515"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Defense, Peer Reviewed Cancer Research Program","award":["CA170674P2"],"award-info":[{"award-number":["CA170674P2"]}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["K23- DK119460"],"award-info":[{"award-number":["K23- DK119460"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Controlled attenuation parameter (CAP) is an ultrasound-based point-of-care method to quantify liver fat; however, the optimal threshold for CAP to detect pathologic liver fat among persons living with human immunodeficiency virus (HIV; PLWH) is unknown. Therefore, we aimed to identify the diagnostic accuracy and optimal threshold of CAP for the detection of liver-fat among PLWH with magnetic resonance imaging proton-density fat fraction (MRI-PDFF) as the reference standard.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients from a prospective single-center cohort of PLWH at risk for HIV-associated nonalcoholic fatty liver disease (NAFLD) who underwent contemporaneous MRI-PDFF and CAP assessment were included. Subjects with other forms of liver disease including viral hepatitis and excessive alcohol intake were excluded. Receiver operatic characteristic (ROC) curve analysis were performed to identify the optimal threshold for the detection of HIV-associated NAFLD (liver fat \u2265 5%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seventy PLWH (90% men) at risk for NAFLD were included. The mean (\u00b1 standard deviation) age and body mass index were 48.6 (\u00b110.2) years and 30 (\u00b1 5.3) kg\/m2, respectively. The prevalence of HIV-associated NAFLD (MRI-PDFF \u2265 5%) was 80%. The M and XL probes were used for 56% and 44% of patients, respectively. The area under the ROC curve of CAP for the detection of MRI-PDFF \u2265 5% was 0.82 (0.69\u20130.95) at the cut-point of 285 dB\/m. The positive predictive value of CAP \u2265 285 dB\/m was 93.2% in this cohort with sensitivity of 73% and specificity of 78.6%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The optimal cut-point of CAP to correctly identify HIV-associated NAFLD was 285 dB\/m, is similar to previously published cut-point for primary NAFLD and may be incorporated into routine care to identify patients at risk of HIV-associated NAFLD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa429","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T03:26:04Z","timestamp":1600917964000},"page":"2124-2131","source":"Crossref","is-referenced-by-count":23,"title":["Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard"],"prefix":"10.1093","volume":"72","author":[{"given":"Veeral H","family":"Ajmera","sequence":"first","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California, USA"},{"name":"Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R","family":"Cachay","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Owen Clinic, University of California San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian B","family":"Ramers","sequence":"additional","affiliation":[{"name":"Laura Rodriguez Research Institute, Family Health Centers of San Diego, San Diego, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Bassirian","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singh","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richele","family":"Bettencourt","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Richards","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Hamilton","sequence":"additional","affiliation":[{"name":"Liver Imaging Group, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Middleton","sequence":"additional","affiliation":[{"name":"Liver Imaging Group, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Fowler","sequence":"additional","affiliation":[{"name":"Liver Imaging Group, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Sirlin","sequence":"additional","affiliation":[{"name":"Liver Imaging Group, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[{"name":"NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California, USA"},{"name":"Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, California, USA"},{"name":"Division of Epidemiology, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"2021061513445858100_CIT0001","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"2021061513445858100_CIT0002","doi-asserted-by":"crossref","first-page":"e0150970","DOI":"10.1371\/journal.pone.0150970","article-title":"A meta-analysis of the metabolic syndrome prevalence in the global HIV-infected population","volume":"11","author":"Nguyen","year":"2016","journal-title":"PLoS One"},{"key":"2021061513445858100_CIT0003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/cid\/ciw285","article-title":"Higher prevalence of hypertension in HIV-1-infected patients on combination antiretroviral therapy is associated with changes in body composition and prior stavudine exposure","volume":"63","author":"van Zoest","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021061513445858100_CIT0004","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/hiv.12516","article-title":"High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC","volume":"18","author":"Levy","year":"2017","journal-title":"HIV Med"},{"key":"2021061513445858100_CIT0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QAI.0b013e318074efe3","article-title":"HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients","volume":"45","author":"Mohammed","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021061513445858100_CIT0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/infdis\/jiu409","article-title":"Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection","volume":"211","author":"Dinh","year":"2015","journal-title":"J Infect Dis"},{"key":"2021061513445858100_CIT0007","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ajg.2014.32","article-title":"Risk factors for fatty liver in the Multicenter AIDS Cohort Study","volume":"109","author":"Price","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2021061513445858100_CIT0008","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"2021061513445858100_CIT0009","doi-asserted-by":"crossref","first-page":"20170587","DOI":"10.1259\/bjr.20170587","article-title":"Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis","volume":"91","author":"Zhang","year":"2018","journal-title":"Br J Radiol"},{"key":"2021061513445858100_CIT0010","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jmri.22580","article-title":"Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy","volume":"34","author":"Reeder","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"2021061513445858100_CIT0011","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.cgh.2015.07.030","article-title":"Incorporation of noninvasive measures of liver fibrosis into clinical practice: diagnosis and prognosis","volume":"13","author":"Asrani","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021061513445858100_CIT0012","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/apt.13405","article-title":"Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE","volume":"43","author":"Doycheva","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2021061513445858100_CIT0013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jhep.2016.06.005","article-title":"MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: clinical trials to clinical practice","volume":"65","author":"Dulai","year":"2016","journal-title":"J Hepatol"},{"key":"2021061513445858100_CIT0014","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.27647","article-title":"Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)","volume":"61","author":"Loomba","year":"2015","journal-title":"Hepatology"},{"key":"2021061513445858100_CIT0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/0284185115580488","article-title":"A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease","volume":"57","author":"Idilman","year":"2016","journal-title":"Acta Radiol"},{"key":"2021061513445858100_CIT0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2036.2012.05121.x","article-title":"Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD","volume":"36","author":"Permutt","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"2021061513445858100_CIT0017","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1148\/radiol.14140754","article-title":"Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease","volume":"274","author":"Tang","year":"2015","journal-title":"Radiology"},{"key":"2021061513445858100_CIT0018","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"2021061513445858100_CIT0019","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"2021061513445858100_CIT0020","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"2021061513445858100_CIT0021","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"2021061513445858100_CIT0022","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"2021061513445858100_CIT0023","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"2021061513445858100_CIT0024","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol"},{"key":"2021061513445858100_CIT0025","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"2021061513445858100_CIT0026","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/apt.12237","article-title":"Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease","volume":"37","author":"Patel","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2021061513445858100_CIT0027","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0000000000001601","article-title":"Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults","volume":"31","author":"Price","year":"2017","journal-title":"AIDS"},{"key":"2021061513445858100_CIT0028","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan","volume":"36","author":"Sasso","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"2021061513445858100_CIT0029","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/MEG.0000000000000339","article-title":"Hepatic steatosis in individuals living with HIV measured by controlled attenuation parameter: a cross-sectional study","volume":"27","author":"Sulyok","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2021061513445858100_CIT0030","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/QAD.0000000000001241","article-title":"Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients","volume":"30","author":"Vuille-Lessard","year":"2016","journal-title":"AIDS"},{"key":"2021061513445858100_CIT0031","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"2021061513445858100_CIT0032","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/infdis\/jiz096","article-title":"Increased prevalence of hepatic steatosis in young adults with lifelong HIV","volume":"220","author":"Aepfelbacher","year":"2019","journal-title":"J Infect Dis"},{"key":"2021061513445858100_CIT0033","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/QAD.0000000000002412","article-title":"Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients","volume":"34","author":"Sebastiani","year":"2020","journal-title":"AIDS"},{"key":"2021061513445858100_CIT0034","doi-asserted-by":"crossref","first-page":"e25201","DOI":"10.1002\/jia2.25201","article-title":"Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy","volume":"21","author":"Perazzo","year":"2018","journal-title":"J Int AIDS Soc"},{"key":"2021061513445858100_CIT0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jhep.2017.05.011","article-title":"Hepatic steatosis progresses faster in HIV mono-infected than HIV\/HCV co-infected patients and is associated with liver fibrosis","volume":"67","author":"Pembroke","year":"2017","journal-title":"J Hepatol"},{"key":"2021061513445858100_CIT0036","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/cid\/cix467","article-title":"Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease","volume":"65","author":"Mac\u00edas","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021061513445858100_CIT0037","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1097\/QAI.0000000000001936","article-title":"Diagnostic accuracy of noninvasive markers of steatosis, nash, and liver fibrosis in HIV-monoinfected individuals at risk of Nonalcoholic Fatty Liver Disease (NAFLD): results from the ECHAM study","volume":"80","author":"Lemoine","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021061513445858100_CIT0038","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"2021061513445858100_CIT0039","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2050640616646528","article-title":"Controlled attenuation parameter using the FibroScan\u00ae XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population","volume":"5","author":"Chan","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"2021061513445858100_CIT0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/hep.29489","article-title":"Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease","volume":"67","author":"Vuppalanchi","year":"2018","journal-title":"Hepatology"},{"key":"2021061513445858100_CIT0041","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s10620-017-4638-3","article-title":"Controlled attenuation parameter (CAP) with the XL probe of the Fibroscan\u00ae: a comparative study with the M probe and liver biopsy","volume":"62","author":"de L\u00e9dinghen","year":"2017","journal-title":"Dig Dis Sci"},{"key":"2021061513445858100_CIT0042","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/hep.30674","article-title":"MRI assessment of treatment response in HIV-associated NAFLD: a randomized trial of a stearoyl-coenzyme-a-desaturase-1 inhibitor (ARRIVE Trial)","volume":"70","author":"Ajmera","year":"2019","journal-title":"Hepatology"},{"key":"2021061513445858100_CIT0043","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1016\/S2352-3018(19)30338-8","article-title":"Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial","volume":"6","author":"Stanley","year":"2019","journal-title":"Lancet HIV"},{"key":"2021061513445858100_CIT0044","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1148\/radiol.12120896","article-title":"Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis","volume":"267","author":"Tang","year":"2013","journal-title":"Radiology"},{"key":"2021061513445858100_CIT0045","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"2021061513445858100_CIT0046","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.gastro.2018.04.014","article-title":"Magnetic resonance imaging proton density fat fraction associates with progression of fibrosis in patients with nonalcoholic fatty liver disease","volume":"155","author":"Ajmera","year":"2018","journal-title":"Gastroenterology"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa429\/33791419\/ciaa429.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/12\/2124\/38646828\/ciaa429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/12\/2124\/38646828\/ciaa429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T13:46:57Z","timestamp":1623764817000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/12\/2124\/5911520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,9,25]]},"published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa429","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,15]]},"published":{"date-parts":[[2020,9,25]]}}}